Within-subject, double-blinded, randomized, and placebo-controlled evaluation of the combined effects of the cannabinoid dronabinol and the opioid hydromorphone in a human laboratory pain model - Dunn, Kelly E.; Bergeria, Cecilia L.; Huhn, Andrew S.; Speed, Traci J.; Mun, Chung Jung; Vandrey, Ryan; Campbell, Claudia M. (Neuropsychopharmacology (New York, N.Y.), 2021)
Keywords: 692/308/1426; 692/308/409; Adult; Adverse events; Analgesia; Analgesics, Opioid; Behavioral Sciences; Biological Psychology; Blindness; Cannabinoids; Capsaicin; Chronic pain; Clinical trials; Cognitive ability; Double-Blind Method; Dronabinol; Drug abuse; Humans; Hydromorphone; Laboratories; Medicine; Medicine & Public Health; Narcotics; Neurosciences; Opioids; Pain; Pain - drug therapy; Pain perception; Pharmacotherapy; Placebos; Psychiatry; Tetrahydrocannabinol